Processable aqueous dispersions of graphene nanosheets
The pattern we see most often: patients start at 5 mg/mL during titration, then switch to 10 mg/mL at maintenance to reduce vial size and injection volume
Each treatment is tailored to the individual after a consultation with one of our healthcare professionals
This cycle may be repeated numerous times and results in significant muscle wasting in patients, thereby increasing the risk of falls and fractures, particularly in the elderly population
DPP-4 Inhibitors As mentioned above, DPP-4 inhibitors are now an established and successful class of oral anti-hyperglycaemic agents, and are firmly embedded in guidelines for treating T2DM patients without atherosclerotic cardiovascular (CV) disease (116, 117)
Therefore, you de-escalate the dose and I would suggest dropping to the next lower dose and maintaining that for at least three months to see where you reset